Ivan Sloma

758 total citations
30 papers, 423 citations indexed

About

Ivan Sloma is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Ivan Sloma has authored 30 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 15 papers in Genetics and 6 papers in Immunology. Recurrent topics in Ivan Sloma's work include Chronic Myeloid Leukemia Treatments (16 papers), Acute Myeloid Leukemia Research (11 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Ivan Sloma is often cited by papers focused on Chronic Myeloid Leukemia Treatments (16 papers), Acute Myeloid Leukemia Research (11 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Ivan Sloma collaborates with scholars based in France, Canada and United States. Ivan Sloma's co-authors include Connie J. Eaves, Xiaoyan Jiang, AC Eaves, Dominique Charron, Catherine Gélin, Nuala Mooney, Ryad Tamouza, Ali G. Turhan, Marc Busson and Rajagopal Krishnamoorthy and has published in prestigious journals such as Blood, The Journal of Immunology and PLoS ONE.

In The Last Decade

Ivan Sloma

26 papers receiving 418 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ivan Sloma France 12 221 169 127 104 60 30 423
Paola Temperani Italy 11 172 0.8× 70 0.4× 137 1.1× 109 1.0× 41 0.7× 29 379
S Furusawa Japan 11 226 1.0× 72 0.4× 90 0.7× 129 1.2× 57 0.9× 35 396
Saskia Gueller United States 14 148 0.7× 48 0.3× 134 1.1× 199 1.9× 80 1.3× 19 468
Jamie Wilhelm United States 6 215 1.0× 44 0.3× 85 0.7× 162 1.6× 96 1.6× 13 369
Cornelis E. Hack Netherlands 7 61 0.3× 148 0.9× 96 0.8× 52 0.5× 20 0.3× 8 295
Myriam Haltalli United Kingdom 9 164 0.7× 171 1.0× 48 0.4× 131 1.3× 44 0.7× 16 373
Jodie Ulaszek United States 6 106 0.5× 66 0.4× 47 0.4× 154 1.5× 64 1.1× 9 329
Ann‐Mari Forsblom Sweden 6 312 1.4× 39 0.2× 170 1.3× 183 1.8× 51 0.8× 12 395
G Fugazza Italy 8 259 1.2× 64 0.4× 60 0.5× 82 0.8× 69 1.1× 14 389
Darlene Monlish United States 11 116 0.5× 228 1.3× 35 0.3× 135 1.3× 68 1.1× 25 387

Countries citing papers authored by Ivan Sloma

Since Specialization
Citations

This map shows the geographic impact of Ivan Sloma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan Sloma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan Sloma more than expected).

Fields of papers citing papers by Ivan Sloma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivan Sloma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan Sloma. The network helps show where Ivan Sloma may publish in the future.

Co-authorship network of co-authors of Ivan Sloma

This figure shows the co-authorship network connecting the top 25 collaborators of Ivan Sloma. A scholar is included among the top collaborators of Ivan Sloma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivan Sloma. Ivan Sloma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luna, Gonzalo De, J Crétin, Rabah Redjoul, et al.. (2025). Screening for clonal hematopoiesis in patients with β-hemoglobinopathies who are candidates to transplant approaches. Blood. 146(Supplement 1). 534–534.
2.
3.
Sloma, Ivan, et al.. (2023). Suivi de la maladie résiduelle dans les leucémies aiguës myéloïdes. Revue Francophone des Laboratoires. 2023(551). 64–74. 1 indexed citations
4.
Redjoul, Rabah, Florence Beckerich, Gonzalo De Luna, et al.. (2022). ABO blood barrier to engraftment after allogeneic stem cell transplantation in sickle cell disease: A case‐story with two successive HLA‐matched sibling donors. American Journal of Hematology. 98(4). 692–696. 1 indexed citations
5.
Dupuy, Aurélie, Erell Guillerm, Philippe Gaulard, et al.. (2022). Evaluation of two new highly multiplexed PCR assays as an alternative to next‐generation sequencing for IDH1/2 mutation detection. Molecular Oncology. 16(22). 3916–3926. 3 indexed citations
6.
Cohen, Justine V., Julien Caldéraro, Aurélie Dupuy, et al.. (2022). High prevalence of unusual KRAS , NRAS , and BRAF mutations in POLE ‐ hypermutated colorectal cancers. Molecular Oncology. 16(17). 3055–3065. 2 indexed citations
7.
Hebert, Nicolas, Meghan Perkins, Ivan Sloma, et al.. (2021). Erythroid Chimerism Measurement As a Predictive Tool of Bone Marrow Transplantation Outcome in Sickle Cell Disease. Blood. 138(Supplement 1). 2028–2028. 1 indexed citations
8.
Sloma, Ivan, Philip Beer, Christophe Desterke, et al.. (2020). Epigenetic and functional changes imposed by NUP98-HOXA9 in a genetically engineered model of chronic myeloid leukemia progression. Haematologica. 106(3). 881–885. 1 indexed citations
9.
Desterke, Christophe, Ivan Sloma, Lucas Eduardo Botelho de Souza, et al.. (2018). Aryl hydrocarbon receptor (AHR) is a novel druggable pathway controlling malignant progenitor proliferation in chronic myeloid leukemia (CML). PLoS ONE. 13(8). e0200923–e0200923. 20 indexed citations
10.
Sloma, Ivan, Maria Teresa Mitjavila‐Garcia, Olivier Féraud, et al.. (2017). Whole-genome analysis reveals unexpected dynamics of mutant subclone development in a patient with JAK2-V617F-positive chronic myeloid leukemia. Experimental Hematology. 53. 48–58. 14 indexed citations
11.
Beer, Philip, David J. H. F. Knapp, Paul H. Miller, et al.. (2014). Disruption of IKAROS activity in primitive chronic-phase CML cells mimics myeloid disease progression. Blood. 125(3). 504–515. 26 indexed citations
12.
Sloma, Ivan, et al.. (2013). Haemophagocytic histiocyte in a peripheral blood film. British Journal of Haematology. 165(2). 163–163. 3 indexed citations
13.
Sloma, Ivan, Philip Beer, Kyi Min Saw, et al.. (2013). Genotypic and functional diversity of phenotypically defined primitive hematopoietic cells in patients with chronic myeloid leukemia. Experimental Hematology. 41(10). 837–847. 9 indexed citations
14.
Sloma, Ivan, Suzan Imren, Philip Beer, et al.. (2012). Ex vivo expansion of normal and chronic myeloid leukemic stem cells without functional alteration using a NUP98HOXA10homeodomain fusion gene. Leukemia. 27(1). 159–169. 13 indexed citations
15.
Sloma, Ivan, Xiaoyan Jiang, AC Eaves, & Connie J. Eaves. (2010). Insights into the stem cells of chronic myeloid leukemia. Leukemia. 24(11). 1823–1833. 85 indexed citations
16.
Gélin, Catherine, Ivan Sloma, Dominique Charron, & Nuala Mooney. (2008). Regulation of MHC II and CD1 antigen presentation: from ubiquity to security. Journal of Leukocyte Biology. 85(2). 215–224. 30 indexed citations
17.
Tamouza, Ryad, Marc Busson, Catherine Fortier, et al.. (2007). HLA-E*0101 allele in homozygous state favors severe bacterial infections in sickle cell anemia. Human Immunology. 68(10). 849–853. 29 indexed citations
18.
Lionnet, François, Claude Bachmeyer, Ivan Sloma, et al.. (2007). Tuberculosis in adult patients with sickle cell disease. Journal of Infection. 55(5). 439–444. 11 indexed citations
19.
Busson, Marc, Ivan Sloma, Manuel Brun, et al.. (2005). Early-Onset Ankylosing Spondylitis Is Associated With a Functional MICA Polymorphism. Human Immunology. 66(10). 1057–1061. 61 indexed citations
20.
Sloma, Ivan, Marie-Thérèse Zilber, Dominique Charron, et al.. (2004). Upregulation and atypical expression of the CD1 molecules on monocytes in sickle cell disease. Human Immunology. 65(11). 1370–1376. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paola Temperani Breakdown of academic impact, for papers by S Furusawa Breakdown of academic impact, for papers by Saskia Gueller Breakdown of academic impact, for papers by Jamie Wilhelm Breakdown of academic impact, for papers by Cornelis E. Hack Breakdown of academic impact, for papers by Myriam Haltalli Breakdown of academic impact, for papers by Jodie Ulaszek Breakdown of academic impact, for papers by Ann‐Mari Forsblom Breakdown of academic impact, for papers by G Fugazza Breakdown of academic impact, for papers by Darlene Monlish
Rankless by CCL
2026